Frazier Life Sciences Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,030,878
| Closed | -$2.65M | – | 55 |
|
|
2024
Q1 | $2.65M | Hold |
1,030,878
| – | – | 0.11% | 48 |
|
|
2023
Q4 | $2.1M | Sell |
1,030,878
-400,000
| -28% | -$816K | 0.11% | 47 |
|
|
2023
Q3 | $2.46M | Sell |
1,430,878
-970,836
| -40% | -$1.67M | 0.16% | 47 |
|
|
2023
Q2 | $4.68M | Sell |
2,401,714
-2,760,634
| -53% | -$5.38M | 0.28% | 43 |
|
|
2023
Q1 | $14.4M | Hold |
5,162,348
| – | – | 1.04% | 24 |
|
|
2022
Q4 | $17.8M | Sell |
5,162,348
-75,000
| -1% | -$259K | 1.11% | 21 |
|
|
2022
Q3 | $13.5M | Hold |
5,237,348
| – | – | 1.04% | 24 |
|
|
2022
Q2 | $12.7M | Hold |
5,237,348
| – | – | 1.2% | 22 |
|
|
2022
Q1 | $21.6M | Buy |
+5,237,348
| New | +$21.6M | 1.84% | 18 |
|